Hepatitis B Mutations and Liver Cancer Risk
Author Information
Author(s): Tong Myron J, Blatt Lawrence M, Kao Jia-Horng, Cheng Jason Tzuying, Corey William G
Primary Institution: The Liver Center, Huntington Medical Research Institutes Pasadena, CA, USA
Hypothesis
The study aims to evaluate the differences in viral factors between chronic hepatitis B carriers and patients with hepatocellular carcinoma (HCC).
Conclusion
The presence of specific mutations in the hepatitis B virus significantly increases the risk of developing HCC in chronic hepatitis B patients.
Supporting Evidence
- HCC patients had significantly higher levels of HBV DNA compared to chronic carriers.
- BCP T1762/A1764 mutants were found in 77.7% of HCC patients compared to 21.2% of chronic carriers.
- PC A1896 mutants were present in 46% of HCC patients versus 30.2% of chronic carriers.
Takeaway
Some people with hepatitis B can get very sick and develop liver cancer, but others don't. This study found that certain changes in the virus can make it more likely for someone to get cancer.
Methodology
The study compared baseline viral profiles of 101 HCC patients with 67 chronic carriers over a follow-up period of up to 16 years.
Potential Biases
Potential bias due to the selection of chronic carriers based on specific criteria.
Limitations
The study relied on a single baseline measurement for HBV DNA and did not perform liver biopsies on chronic carriers.
Participant Demographics
The study included 101 HCC patients and 67 chronic carriers, predominantly Asian, with a mean age of 53.3 years for HCC patients and 45.4 years for chronic carriers.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI 3.05–40.72 for BCP T1762/A1764 mutants; 95% CI 1.14–12.34 for PC A1896 mutants
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website